News results

Showing 1 - 10 of 817 results

Government of Canada increases access to COVID-19 rapid testing for workers

| Health Canada | news releases

Today, the Honourable Patty Hajdu, Minister of Health and the Honourable Mary Ng, Minister of Small Business, Export Promotion and International Trade, are encouraging businesses and organizations to apply for free rapid tests for workplace screening projects. Workplace screening is another layer of protection for workers, the people they serve and their communities from COVID-19.


Government of Canada Invests $3.1 Million to Expand Virtual Health Care Services in the Northwest Territories

| Health Canada | news releases

Today, the Honourable Patty Hajdu, Minister of Health, announced the signature of a bilateral agreement with the Northwest Territories to expand virtual health care services for its residents. Under the agreement, the territory will invest federal funding based on agreed-upon pan-Canadian priorities for accelerating virtual health care services during the pandemic.


Government of Canada continues to take action to support people with chronic pain

| Health Canada | news releases

Today, the Honourable Patty Hajdu, Minister of Health, announced the release of the Canadian Pain Task Force’s (CPTF) third and final report — "An Action Plan for Pain in Canada". The Minister also announced $2.8 million in funding for the Centre of Effective Practice for a project that will help provide support and access to care for people living with chronic pain.


Update on COVID-19 vaccines

| Health Canada | media advisories

On May 5, 2021, Health Canada officials will hold a technical briefing for media to provide an update on regulatory authorization for the Pfizer-BioNTech COVID-19 vaccine.


Statement from Health Canada on Janssen COVID-19 vaccines and Emergent BioSolutions

| Health Canada | statements

On April 25, 2021, Health Canada issued a statement regarding the U.S. Food and Drug Administration’s (FDA) recent inspection of the Emergent BioSolutions facility in Baltimore, Maryland, which noted multiple areas of concern. The Department continues to work with Janssen, AstraZeneca, and the FDA to ensure the facility meets manufacturing standards, and that all vaccine supplies for Canada are of high quality. Since issuing our statement, Health Canada has learned that a drug substance produced at the Emergent site was used in the manufacturing of the initial Janssen vaccines received on April 28 and intended for use in Canada.


Statement from Health Canada on AstraZeneca and Janssen COVID-19 vaccines produced at Emergent BioSolutions

| Health Canada | statements

Health Canada is aware of the U.S. Food and Drug Administration’s (FDA) recent inspection of the Emergent BioSolutions facility in Baltimore, Maryland, which noted multiple areas of concern. Health Canada would like to reassure Canadians that all AstraZeneca vaccines imported into Canada from this facility are safe and of high quality. Janssen vaccines produced at this site have not entered the country.


Government of Canada Assessment Concludes that Talc May be Harmful to Human Health

| Health Canada | news releases

Under the Chemicals Management Plan, Health Canada and Environment and Climate Change Canada have completed a final screening assessment of talc, a mineral used in many consumer products. Most uses of talc are not a concern to human health. However, based on the latest science and the final screening assessment completed in 2021, the Government of Canada concludes that talc may be harmful to lungs when inhaling certain loose talc powder products, and it may cause ovarian cancer when using certain self-care products containing talc in the female genital area.


Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: